LAE-103

N/A

Report date: 2025/08/05 17:46:01

Base Information

Drug NameLAE-103
Drug Alias NameLAE-103LAE103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionActivin receptor type-2B inhibitors
TargetsActivin receptor type-2B
Therapy Area/IndicationsObesitySarcopeniaMuscular Disorders, Atrophic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesLaekna Therapeutics Shanghai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLaekna Therapeutics Shanghai Co Ltd
Inactive CompaniesN/A
Active IndicationsObesitySarcopeniaMuscular Disorders, Atrophic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A